Jon Dobson

Co-Founder, Chief Technology Officer

Dr. Dobson received his B.Sc. and M.Sc. degrees from the University of Florida and his Ph.D. in Natural Sciences from The Swiss Federal Institute of Technology (ETH-Zurich). From 2000 until 2011, he worked at Keele University in the United Kingdom, becoming a full professor of biophysics and biomedical engineering in 2003. He returned to UF as faculty in 2011, and a year later was appointed as the founding director of its cross-departmental Institute for Cell Engineering and Regenerative Medicine (ICERM). Dr. Dobson has been appointed as a fellow of the US National Academy of Inventors (2019), the American Association for the Advancement of Science (AAAS, 2015), the American Institute for Medical and Biological Engineering (AIMBE, 2015), the Royal Society of Biology (2012), and the Royal Society of Medicine (2007). He has also been recognized through the International Journal of Nanomedicine Distinguished Scientist Award (2017), the UK Medical Research Council Césare Milstein Award (2008) and the Royal Society of London Wolfson Research merit Award (2004). He been involved on the editorial board for fifteen scientific journals.

Dr. Dobson’s research focuses on biomedical applications of magnetic micro- and nanoparticles. His group has developed novel technologies for (i) magnetic targeting and remote activation of cell signaling pathways for cell engineering and stem cell therapy; (ii) magnetic nanoparticle-based gene transfection delivery; and (iii) magnetic targeting of modified cell carriers for cancer therapy and regenerative medicine. In addition, he has also led a multi-national research program developing novel imaging and characterization techniques to quantify, characterize and map iron compounds related to neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Dr. Dobson has 35 issued and pending patents across the world, over 160 peer-reviewed publications, 8 peer-reviewed book chapters, and a book based on his research and expertise in magnetic technology.

View his publication history on Google Scholar (https://scholar.google.com/citations?user=dQvJ_XgAAAAJ&hl=en&oi=ao)

Selected Publications

  • Dobson, J and SH Cartmell (2020) Nanomagnetic actuation: Controlling cell behaviour with magnetic nanoparticles. In: Biomedical Applications of Magnetic Particles, J Anker and T Mefford (Eds.) CRC Press/Taylor & Francis, pp. 159-176. ISBN: 9781439839683

  • Lanier, OL, AG Monsalve, PS McFetridge, J Dobson (2018) Magnetically triggered release of biologics. International Materials Reviews 64: 63-90.

  • Pankhurst, QA, S Jones, J Dobson (2016) Viewpoint – Applications of magnetic nanoparticles in biomedicine - the story so far. Journal of Physics D: Applied Physics 49: 201002 (2 pp).

  • Kozissnik, B and J Dobson (2013) Biomedical applications of magnetic nanoparticles. MRS Bulletin 38: 927-931.

  • Pankhurst, QA, NKT Thanh, SK Jones, J Dobson (2009) Progress in applications of magnetic nanoparticles in biomedicine. Journal of Physics D: Applied Physics 42: 224001 (15pp).

  • Dobson, J (2008) Nanomagnetic actuation: remote control of cells. Nature Nanotechnology 3: 139-143.

  • McBain, S, HPP Yiu, J Dobson (2008) Magnetic nanoparticles for drug and gene delivery. International Journal of Nanomedicine 3: 169-180.

  • Dobson, J (2006) Magnetic nanoparticles for drug delivery. Drug Development Research 67: 55-60.

  • Everett, J, JF Collingwood, V Tjendana-Tjhin, G Plascencia-Villa, I Hands-Portman, J Dobson, T Tyliszczak, G Perry, ND Telling (2018) Nanoscale synchrotron x-ray speciation of ferrous iron and calcium compounds in amyloid plaque cores from Alzheimer’s disease subjects. Nanoscale 10: 11782-11796.

  • Dobson, J (2006) Magnetic nanoparticle-based, non-viral gene delivery. Gene Therapy 13: 283-287.